287 related articles for article (PubMed ID: 34277702)
1. Oxygen-Based Nanocarriers to Modulate Tumor Hypoxia for Ameliorated Anti-Tumor Therapy: Fabrications, Properties, and Future Directions.
Li X; Wu Y; Zhang R; Bai W; Ye T; Wang S
Front Mol Biosci; 2021; 8():683519. PubMed ID: 34277702
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine-Enabled Modulation of Tumor Hypoxic Microenvironment for Enhanced Cancer Therapy.
Wang J; Zhang B; Sun J; Wang Y; Wang H
Adv Ther (Weinh); 2020 Jan; 3(1):. PubMed ID: 34277929
[TBL] [Abstract][Full Text] [Related]
4. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
[TBL] [Abstract][Full Text] [Related]
5. Modulating tumor hypoxia by nanomedicine for effective cancer therapy.
Jahanban-Esfahlan R; de la Guardia M; Ahmadi D; Yousefi B
J Cell Physiol; 2018 Mar; 233(3):2019-2031. PubMed ID: 28198007
[TBL] [Abstract][Full Text] [Related]
6. Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences.
Zhang A; Meng K; Liu Y; Pan Y; Qu W; Chen D; Xie S
Adv Colloid Interface Sci; 2020 Oct; 284():102261. PubMed ID: 32942181
[TBL] [Abstract][Full Text] [Related]
7. Recent Progress of Alkyl Radicals Generation-Based Agents for Biomedical Applications.
Lee KW; Wan Y; Li X; Cui X; Li S; Lee CS
Adv Healthc Mater; 2021 May; 10(10):e2100055. PubMed ID: 33738983
[TBL] [Abstract][Full Text] [Related]
8. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
9. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
Yang Y; Zhang M; Song H; Yu C
Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
Kwon S; Ko H; You DG; Kataoka K; Park JH
Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-responsive nanocarriers for cancer imaging and therapy: recent approaches and future perspectives.
Thambi T; Park JH; Lee DS
Chem Commun (Camb); 2016 Jun; 52(55):8492-500. PubMed ID: 27225824
[TBL] [Abstract][Full Text] [Related]
12. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
13. Engineering white blood cell membrane-camouflaged nanocarriers for inflammation-related therapeutics.
Song W; Jia P; Ren Y; Xue J; Zhou B; Xu X; Shan Y; Deng J; Zhou Q
Bioact Mater; 2023 May; 23():80-100. PubMed ID: 36406250
[TBL] [Abstract][Full Text] [Related]
14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
15. Drug nanocrystals for cancer therapy.
Miao X; Yang W; Feng T; Lin J; Huang P
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 May; 10(3):e1499. PubMed ID: 29044971
[TBL] [Abstract][Full Text] [Related]
16. The development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy.
Han D; Zhang X; Ma Y; Yang X; Li Z
Mater Today Bio; 2023 Feb; 18():100517. PubMed ID: 36578285
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy.
Xie Z; Guo W; Guo N; Huangfu M; Liu H; Lin M; Xu W; Chen J; Wang T; Wei Q; Han M; Gao J
Acta Biomater; 2018 Apr; 71():351-362. PubMed ID: 29545193
[TBL] [Abstract][Full Text] [Related]
18. Photoluminescent Gold Nanoclusters in Cancer Cells: Cellular Uptake, Toxicity, and Generation of Reactive Oxygen Species.
Matulionyte M; Dapkute D; Budenaite L; Jarockyte G; Rotomskis R
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208642
[TBL] [Abstract][Full Text] [Related]
19. Recent Progress in the Development of Multifunctional Nanoplatform for Precise Tumor Phototherapy.
Liu J; Shi J; Nie W; Wang S; Liu G; Cai K
Adv Healthc Mater; 2021 Jan; 10(1):e2001207. PubMed ID: 33000920
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance.
Yang J; Li W; Luo L; Jiang M; Zhu C; Qin B; Yin H; Yuan X; Yin X; Zhang J; Luo Z; Du Y; You J
Biomaterials; 2018 Nov; 182():145-156. PubMed ID: 30121013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
